Showing results (1751-1760 of 1,902) with videos related to

Sort By:
Pageof 191
Brachytherapy|February 8, 2007
Interstitial implant alone or in combination with external beam radiation therapy for intermediate-risk prostate cancer: a survey of practice patterns in the United StatesSteven J Frank, Peter D Grimm, John E Sylvester, et al.
Cell Reports. Medicine|November 17, 2022
Extensive preclinical validation of combined RMC-4550 and LY3214996 supports clinical investigation for KRAS mutant pancreatic cancerKatrin J Frank, Antonio Mulero-Sánchez, Alexandra Berninger, et al.
The Laryngoscope|February 14, 2019
Outcomes of carotid-sparing IMRT for T1 glottic cancer: Comparison with conventional radiationAbdallah S R Mohamed, Blaine D Smith, Joshua B Smith, et al.
Clinical and Translational Medicine|July 9, 2022
Identification of growth hormone receptor as a relevant target for precision medicine in low-EGFR expressing glioblastomaMaïté Verreault, Irma Segoviano Vilchis, Shai Rosenberg, et al.
Cancer|November 20, 2019
Contemporary prostate cancer treatment choices in multidisciplinary clinics referenced to national trendsChad Tang, Karen E Hoffman, Pamela K Allen, et al.
Blood Cancer Journal|April 4, 2026
Dynamics of BCMA expression in patients with relapsed/refractory multiple myeloma receiving BCMA-directed CAR-T therapyMasooma Shifa Rana, Sebastian Fernandez-Pol, Alexandria Jensen, et al.
Oral Oncology Reports|April 19, 2024
Temporal characterization of acute pain and toxicity kinetics during radiation therapy for head and neck cancer. A retrospective studyVivian Salama, Sara Youssef, Tianlin Xu, et al.
European Urology|September 20, 2014
Defining a standard set of patient-centered outcomes for men with localized prostate cancerNeil E Martin, Laura Massey, Caleb Stowell, et al.
Cancer Discovery|January 8, 2025
Effects of an Initial Anti-CD19 CAR T-cell Therapy on Subsequent Anti-CD22 CAR T-cell Manufacturing and Clinical Outcomes in Patients with Relapsed/Refractory LBCLYi-Jiun Su, Anne Marijn Kramer, Mark P Hamilton, et al.
Cancer|February 13, 2019
Usefulness of surveillance imaging in patients with head and neck cancer who are treated with definitive radiotherapySweet Ping Ng, Courtney Pollard, Joel Berends, et al.
Pageof 191